Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Caution evidenceCoverage 5/5 core metricsLatest reported annual revenue changed -18.3% from the prior reported annual observation.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Revenue contracted
Latest reported annual revenue changed -18.3% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Operating margin compressed
Operating margin changed -58.9 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Free cash flow was negative
Latest reported free cash flow was -$103M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
- 1 filing risk check flagged
Flagged areas: Earnings quality.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Earnings quality
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Insecticides$1.57B45.4%-33.9% yoy
- Herbicides$1.25B36.0%-2.6% yoy
- Fungicides$363M10.5%+2.9% yoy
- Plant Health$191M5.5%-4.8% yoy
- Product And Service Other$94.1M2.7%+171.2% yoy
Members sum to the consolidated $3.47B for this period.
- Latin America$1.35Bshare n/a-2.7% yoy
- Brazil$1.12Bshare n/a+3.3% yoy
- North America$1.1Bshare n/a-6.1% yoy
- United States$923Mshare n/a-8.0% yoy
- EMEA$872Mshare n/a+4.4% yoy
- Asia$142Mshare n/a-83.2% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Insecticides$424M48.8%-19.4% yoy
- Herbicides$318M36.7%-15.4% yoy
- Fungicides$88.4M10.2%+10.0% yoy
- Plant Health$36.3M4.2%-19.2% yoy
- Product And Service Other$700K0.1%-97.1% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 3,990 US-listed filers · 777 in Materials| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $3.5B | 75thof 3,301 top third | 84thof 522 top third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -18.3% | 7thof 3,137 bottom third | 14thof 473 bottom third |
Gross margin gross profit ÷ revenue | 37.0% | 48thof 1,603 middle third | 59thof 221 middle third |
Operating margin operating income ÷ revenue | -47.0% | 21stof 2,819 bottom third | 46thof 483 middle third |
Net margin net income ÷ revenue | -64.6% | 17thof 3,263 bottom third | 40thof 518 middle third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | -3.0% | 30thof 2,679 bottom third | 51stof 433 middle third |
Return on equity net income ÷ stockholders' equity (positive equity only) | -108.1% | 11thof 3,576 bottom third | 23rdof 701 bottom third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 0.7% | 78thof 2,895 top third | 85thof 476 top third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 217 days | 3rdof 2,398 bottom third | 4thof 387 bottom third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
Not available for FMC yet: Earnings-quality fields arrive with this issuer's next re-crawl (sec_screen_v6)..
Point-in-time ledger
Not available for FMC yet: The point-in-time ledger arrives with this issuer's next re-crawl (sec_screen_v6)..
Notes by disclosure type
debt, leases, revenue, segments, contingencies, taxes and more · the filer's own wordsDebt · 4,493 characters as filed
"Debt Debt maturing within one year: Debt maturing within one year consists of the following: December 31, (in Millions) 2025 2024 Short-term foreign debt (1) $ 76.5 $ 135.7 Revolving Credit Facility (2) 643.0 Commercial paper 125.6 Total short-term debt $ 719.5 $ 261.3 Current portion of long-term debt 585.6 76.1 Total short-term debt and current portion of long-term debt $ 1,305.1 $ 337.4 ___________________________ (1) At December 31, 2025, the average effective interest rate on the borrowings was 11.1 percent. (2) At December 31, 2025, the average effective interest rate on the borrowings was 5.8 percent. Revolving Credit Facility The Fifth Amended and Restated Credit Agreement, dated as of June 17, 2022 (the ""Revolving Credit Facility"") allows the Company to borrow up to $2 billion, with the option to increase the capacity of the facility up to $2.75 billion. As of December 31, 2025, borrowings under the Revolving Credit Facility were $643.0 million. In accordance with U.S. GAAP, we have classified the borrowings as short-term debt. The Company intends to refinance any draw under the line of credit with successive short-term borrowings, as needed, through the maturity date in 2028. Letters of credit outstanding under the Revolving Credit Facility totaled $209.8 million and available funds under this facility were $1,147.2 million at December 31, 2025. Long-term debt: Long-term debt consists of the following: (in Millions) December 31, 2025 December 31, Interest Rate Pe …
DebtDisclosureTextBlock · excerpt; the full note is in the filing
Revenue disaggregation · 1,925 characters as filed
The following table provides information about disaggregated revenue by major geographical region: Year Ended December 31, (in Millions) 2025 2024 2023 North America (1) $ 1,102.2 $ 1,173.4 $ 1,204.8 Latin America (1) 1,351.4 1,389.5 1,401.1 Europe, Middle East & Africa 871.5 834.8 899.2 Asia (2) 142.3 848.4 981.7 Total Revenue $ 3,467.4 $ 4,246.1 $ 4,486.8 ____________________ (1) Countries with sales in excess of 10 percent of consolidated revenue consisted of the U.S. and Brazil. Sales for the years ended December 31, 2025, 2024, and 2023 for the U.S. totaled $923.1 million, $1,003.1 million and $978.1 million, respectively, and for Brazil totaled $1,116.5 million, $1,081.1 million and $1,017.3 million, respectively. (2) During the twelve months ended December 31, 2025, we took several one-time commercial actions to prepare the India commercial business for sale. These one-time actions to position the India business for sale resulted in revenue charges of $422 million for the India business in 2025 and included the recognition of actual inventory returns during the period, an increase to the reserve for future sales returns, and various pricing actions to assist with the acceleration of receivable collection. Refer to Note 1 for further details on the India held for sale business. The following table provides information about disaggregated revenue by major product category: Year Ended December 31, (in Millions) 2025 2024 2023 Insecticides $ 1,572.7 $ 2,377.9 $ 2,639.4 …
DisaggregationOfRevenueTableTextBlock · excerpt; the full note is in the filing
Share-based compensation · 9,251 characters as filed
"Share-based Compensation Stock Compensation Plans We have a share-based compensation plan, which has been approved by the stockholders, for certain employees, officers and directors. This plan is described below. FMC Corporation Incentive Compensation and Stock Plan The FMC Corporation 2023 Incentive Stock Plan (the ""Plan"") was approved on April 27, 2023, and provides for the grant of a variety of cash and equity awards to officers, directors, employees and consultants, including stock options, restricted stock, performance units (including restricted stock units), stock appreciation rights, and multi-year management incentive awards payable partly in cash and partly in common stock. The Compensation and Organization Committee of the Board of Directors (the ""Committee""), subject to the provisions of the Plan, approves financial targets, award grants, and the times and conditions for payment of awards to employees. Approximately 2.5 million shares of common stock are available for future grants of share based awards under the Plan as of December 31, 2025. The FMC Corporation Non-Employee Directors Compensation Policy, administered by the Nominating and Corporate Governance Committee of the Board of Directors, sets forth the compensation to be paid to the directors, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance-based restricted stock units, and cash awards to be made to directors under the Plan. Stock options gran …
DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock · excerpt; the full note is in the filing
Goodwill and intangibles · 3,169 characters as filed
Goodwill and Intangible Assets The changes in the carrying amount of goodwill for the years ended December 31, 2025 and 2024 are presented in the table below: (in Millions) Total Balance, December 31, 2023 $ 1,593.6 GSS divestiture allocation (See Note 1.) (71.1) Foreign currency and other adjustments (15.5) Balance, December 31, 2024 $ 1,507.0 India held for sale (See Note 1.) (163.1) GSS divestiture allocation (See Note 1.) (5.9) Foreign currency and other adjustments 18.2 Write-off of goodwill (1,356.2) Balance, December 31, 2025 $ Our fiscal year 2025 annual goodwill and indefinite life impairment test was performed during the third quarter ended September 30, 2025. At the time of the annual impairment test, we determined no goodwill impairment existed and that the fair value was in excess of the carrying value. Additionally, no indefinite-lived asset impairment existed and the estimated fair values also exceeded the carrying value for each of our indefinite-lived intangible assets. As a result of the significant decrease in our stock price during the fourth quarter of 2025, we performed a test of our goodwill and other intangible assets for impairment in connection with the preparation of our financial statements for the year ending December 31, 2025. We recorded a $1,356.2 million write-off of our remaining goodwill balance in connection with the impairment test. There was no impairment identified on our other intangible assets. Our intangible assets, other than goodwil …
GoodwillAndIntangibleAssetsDisclosureTextBlock · excerpt; the full note is in the filing
Income taxes · 14,714 characters as filed
"Income Taxes Domestic and foreign components of income (loss) from continuing operations before income taxes are shown below: Year Ended December 31, (in Millions) 2025 2024 2023 Domestic $ (541.5) $ (271.6) $ (312.7) Foreign (1,345.1) 524.1 612.9 Total $ (1,886.6) $ 252.5 $ 300.2 The provision (benefit) for income taxes attributable to income (loss) from continuing operations consisted of: Year Ended December 31, (in Millions) 2025 2024 2023 Current: Federal $ 3.6 $ 28.2 $ 58.5 Foreign 5.4 160.2 113.9 State 0.4 1.0 1.1 Total current $ 9.4 $ 189.4 $ 173.5 Deferred: Federal $ 8.3 $ (66.0) $ (82.7) Foreign 295.3 (271.9) (1,212.0) State 1.2 (2.4) 1.9 Total deferred $ 304.8 $ (340.3) $ (1,292.8) Total $ 314.2 $ (150.9) $ (1,119.3) A reconciliation of the provision for income taxes to the amount computed by applying the 21% statutory U.S. federal income tax rate to income before income taxes after the adoption of ASU 2023-09 is as follows: Year Ended December 31, (in Millions) 2025 Amount Percent Tax at U.S. Federal statutory rate $ (396.2) 21.0 % State and local income taxes - net (1) 1.6 (0.1) % Foreign tax effects Brazil Goodwill impairment 21.5 (1.1) % Other (5.0) 0.3 % Denmark Goodwill impairment 119.8 (6.4) % Other (11.0) 0.6 % India Changes in valuation allowances 97.7 (5.2) % Other (7.0) 0.4 % Luxembourg Changes in valuation allowances (228.8) 12.1 % Entity liquidation 228.8 (12.1) % Switzerland Changes in valuation allowances 289.3 (15.3) % Goodwill impairment 46.1 (2.4) …
IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing
Leases · 5,168 characters as filed
"Leases We lease office space, vehicles and other equipment under non-cancellable leases with initial terms typically ranging from 1 to 20 years, with some leases having terms greater than 20 years. Our lease portfolio includes agreements with renewal options, purchase options and clauses for early termination based on the terms specific to the agreement. At contract inception, we review the facts and circumstances of the arrangement to determine if the contract is a lease. We follow the guidance in ASC 842-10-15 and consider the following: whether the contract has an identified asset; if we have the right to obtain substantially all economic benefits from the asset; and if we have the right to direct the use of the underlying asset. All leased assets are classified as operating or finance under ASC 842. To determine the present value of future minimum lease payments, we use the implicit rate when readily determinable or our incremental borrowing rate at the lease commencement date. When determining our incremental borrowing rate, we consider our centralized treasury function and our current credit profile. We then make adjustments to this rate for securitization, the length of the lease term, and leases denominated in foreign currencies. Minimum lease payments are expensed over the term of the lease on a straight-line basis. Some leases may require additional contingent or variable lease payments based on factors specific to the individual agreement. Variable lease payments …
LesseeOperatingLeasesTextBlock · excerpt; the full note is in the filing
New accounting pronouncements · 1,469 characters as filed
New accounting guidance and regulatory items On November 4, 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures, to require disaggregation of certain expense captions into specified categories in disclosures within the notes of the financial statements. The standard is effective for FMC beginning with the Form 10-K for the year ended December 31, 2027 and early adoption is permitted. The guidance is required to be applied prospectively and amendments in the ASU may be applied prospectively or retrospectively. We are currently evaluating the impacts this standard will have on our disclosures. Recently adopted accounting guidance On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Changes to the Disclosure Requirements for Income Taxes , to improve the transparency and decision usefulness of income tax disclosures. The standard requires companies to disclose a tabular effective rate reconciliation with certain reconciling items broken out by nature and/or jurisdiction as well as more robust disclosures of income taxes paid, specifically broken out between federal, state and foreign. The ASU is effective for FMC beginning with the Form 10-K for the year ended December 31, 2025, and, as such, we have adopted the new disclosure requirements for this Form 10-K. Refer to Note 11 to the consolidated financial statements for the required disclosures.
NewAccountingPronouncementsPolicyPolicyTextBlock
Pensions and post-retirement benefits · 12,188 characters as filed
"Pension and Other Postretirement Benefits The funded status of our U.S. qualified and nonqualified defined benefit pension plans, our Germany, France, and Belgium defined benefit pension plans, plus our U.S. other postretirement healthcare and life insurance benefit plans for continuing operations, together with the associated balances and net periodic benefit cost recognized in our consolidated financial statements as of December 31, are shown in the tables below. We are required to recognize in our consolidated balance sheets the overfunded and underfunded status of our defined benefit postretirement plans. The overfunded or underfunded status is defined as the difference between the fair value of plan assets and the projected benefit obligation. We are also required to recognize as a component of other comprehensive income the actuarial gains and losses and the prior service costs and credits that arise during the period. The following table summarizes the weighted-average assumptions used to determine the benefit obligations at December 31 for the U.S. Plans: Pensions and Other Benefits December 31, 2025 2024 Discount rate qualified 5.32 % 5.60 % Discount rate nonqualified plan 4.71 % 5.31 % Discount rate other benefits 4.89 % 5.40 % Rate of compensation increase 3.10 % 3.10 % The following table summarizes the components of our defined benefit postretirement plans and reflect a measurement date of December 31: Pensions Other Benefits (1) December 31, (in Millions) 2025 …
PensionAndOtherPostretirementBenefitsDisclosureTextBlock · excerpt; the full note is in the filing
Revenue recognition · 14,905 characters as filed
"Revenue Recognition Disaggregation of revenue We disaggregate revenue from contracts with customers by geographical areas and major product categories. We have three major agricultural product categories: insecticides, herbicides, and fungicides. Plant health, which includes biological products, is also included in the table below. The following table provides information about disaggregated revenue by major geographical region: Year Ended December 31, (in Millions) 2025 2024 2023 North America (1) $ 1,102.2 $ 1,173.4 $ 1,204.8 Latin America (1) 1,351.4 1,389.5 1,401.1 Europe, Middle East & Africa 871.5 834.8 899.2 Asia (2) 142.3 848.4 981.7 Total Revenue $ 3,467.4 $ 4,246.1 $ 4,486.8 ____________________ (1) Countries with sales in excess of 10 percent of consolidated revenue consisted of the U.S. and Brazil. Sales for the years ended December 31, 2025, 2024, and 2023 for the U.S. totaled $923.1 million, $1,003.1 million and $978.1 million, respectively, and for Brazil totaled $1,116.5 million, $1,081.1 million and $1,017.3 million, respectively. (2) During the twelve months ended December 31, 2025, we took several one-time commercial actions to prepare the India commercial business for sale. These one-time actions to position the India business for sale resulted in revenue charges of $422 million for the India business in 2025 and included the recognition of actual inventory returns during the period, an increase to the reserve for future sales returns, and various pri …
RevenueFromContractWithCustomerTextBlock · excerpt; the full note is in the filing
Segment reporting · 2,466 characters as filed
"Segment Information As discussed in Note 1 to the consolidated financial statements included within this Form 10-K, we operate as a single business segment providing innovative solutions to growers around the world with a robust product portfolio fueled by a market-driven discovery and development pipeline in crop protection and plant health. We have determined that the Chief Executive Officer (the CEO) serves as the Chief Operating Decision Maker (""CODM"") for the Company. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets and both planning and forecasting future periods. The CEO reviews consolidated net income (loss) as a key performance measure of profit (loss) for the Companys single segment and reviews significant expenses, if relevant, on a consolidated basis consistent with the presentation on the consolidated statements of income (loss). The CEOs review is focused on consolidated results for the Company. However, the CEO may receive supplemental information as part of his review, which includes revenue by geographic region as well as by major product category. For the presentation of disaggregated revenue, refer to Note 3 to the consolidated financial statements included within this Form 10-K. The following table provides our long-lived assets by major geographical region: (in Millions) December 31, 2025 2 …
SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing
Stockholders' equity · 6,946 characters as filed
"Equity The following is a summary of our capital stock activity over the past three years: Common Stock Shares Treasury Stock Shares December 31, 2022 185,983,792 60,872,988 Stock options and awards (301,008) Repurchases of common stock, net 651,052 December 31, 2023 185,983,792 61,223,032 Stock options and awards (122,288) Repurchases of common stock, net 42,146 December 31, 2024 185,983,792 61,142,890 Stock options and awards (144,664) Repurchases of common stock, net 51,510 December 31, 2025 185,983,792 61,049,736 Accumulated other comprehensive income (loss) Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax. (in Millions) Foreign currency adjustments Derivative Instruments (1) Pension and other postretirement benefits (2) Total Accumulated other comprehensive income (loss), net of tax at December 31, 2022 $ (160.5) $ (51.7) $ (247.4) $ (459.6) 2023 Activity Other comprehensive income (loss) before reclassifications $ 29.2 $ (72.4) $ 11.4 $ (31.8) Amounts reclassified from accumulated other comprehensive income (loss) 73.9 11.0 84.9 Accumulated other comprehensive income (loss), net of tax at December 31, 2023 $ (131.3) $ (50.2) $ (225.0) $ (406.5) 2024 Activity Other comprehensive income (loss) before reclassifications $ (52.6) $ 33.2 $ 4.9 $ (14.5) Amounts reclassified from accumulated other comprehensive income (loss) (0.5) 10.9 10.4 Accumulated other comprehensive income (loss), net of tax at December 31, 2024 $ (183.9) …
StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing
Debt · 6,100 characters as filed
"Debt Debt maturing within one year: (in Millions) June 30, 2026 December 31, 2025 Short-term foreign debt (1) $ 66.5 $ 76.5 Revolving Credit Facility (2) 250.5 643.0 Total short-term debt $ 317.0 $ 719.5 Current portion of long-term debt 9.3 585.6 Total short-term debt and current portion of long-term debt $ 326.3 $ 1,305.1 ____________________ (1) At June 30, 2026, the average effective interest rate on the borrowings was 12.8 percent. (2) At June 30, 2026, the average effective interest rate on the borrowings was 5.9 percent. Revolving Credit Facility The Fifth Amended and Restated Credit Agreement, dated as of June 17, 2022 (the ""Revolving Credit Facility"") allows the Company to borrow up to $2 billion, with the option to increase the capacity of the facility up to $2.75 billion. As of June 30, 2026, borrowings under the Revolving Credit Facility were $250.5 million. In accordance with U.S. GAAP, we have classified the borrowings as short-term debt. The Company intends to refinance any draw under the line of credit with successive short-term borrowings, as needed, through the maturity date in 2028. Letters of credit outstanding under the Revolving Credit Facility totaled $188.6 million and available funds under this facility were $1,560.9 million at June 30, 2026. Long-term debt: (in Millions) June 30, 2026 Interest Rate Percentage Maturity Date June 30, 2026 December 31, 2025 Pollution control and industrial revenue bonds (less unamortized discounts of $0.1 in each per …
DebtDisclosureTextBlock · excerpt; the full note is in the filing
Revenue disaggregation · 821 characters as filed
The following table provides information about disaggregated revenue by major geographical region: Three Months Ended June 30, Six Months Ended June 30, (in Millions) 2026 2025 2026 2025 North America $ 248.8 $ 320.9 $ 446.4 $ 507.3 Latin America 277.9 310.4 454.9 517.2 Europe, Middle East & Africa (EMEA) 214.1 260.4 521.0 533.2 Asia 126.3 158.8 203.4 284.2 Total Revenue $ 867.1 $ 1,050.5 $ 1,625.7 $ 1,841.9 The following table provides information about disaggregated revenue by major product category: Three Months Ended June 30, Six Months Ended June 30, (in Millions) 2026 2025 2026 2025 Insecticides $ 423.5 $ 525.3 $ 764.1 $ 928.0 Herbicides 318.2 376.0 631.9 648.2 Fungicides 88.4 80.4 144.2 133.1 Plant Health 36.3 44.9 84.1 90.1 Other 0.7 23.9 1.4 42.5 Total Revenue $ 867.1 $ 1,050.5 $ 1,625.7 $ 1,841.9
DisaggregationOfRevenueTableTextBlock
Income taxes · 2,669 characters as filed
"Income Taxes Our effective income tax rates from continuing operations for the three and six months ended June 30, 2026 were 0.8 percent and negative 32.2 percent, respectively. Our effective income tax rates from continuing operations for the three and six months ended June 30, 2025 were 24.5 percent and 43.8 percent, respectively. The change in the effective tax rate for the three months ended June 30, 2026 compared to the three months ended June 30, 2025 was primarily due to global mix of earnings as well as tax impacts of restructuring activity during the period. The change in the effective tax rate for the six months ended June 30, 2026 was primarily due to global mix of earnings, tax impacts of restructuring activity, and additional valuation allowance of historical net deferred tax assets in Switzerland. As a result of changes in global earnings mix and ongoing tax planning implemented in March 2026, we reevaluated the realizability of our historical deferred tax assets and recorded an increase to our valuation allowance in Switzerland of approximately $123 million during the six months ended June 30, 2026. We determine our interim tax provision using an Estimated Annual Effective Tax Rate methodology (""EAETR"") in accordance with U.S. GAAP. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision. The determination of the EAETR is b …
IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing
Leases · 2,129 characters as filed
Leases For additional detail on the Company's leases and related policies, see Note 16 to our consolidated financial statements included within our 2025 Form 10-K. The ROU asset and lease liability balances as of June 30, 2026 and December 31, 2025 were as follows: (in Millions) Classification June 30, 2026 December 31, 2025 Assets Operating lease ROU assets Other assets including long-term receivables, net $ 103.5 $ 104.9 Liabilities Operating lease current liabilities Accrued and other liabilities $ 27.8 $ 26.3 Operating lease noncurrent liabilities Other long-term liabilities 94.3 97.6 The components of lease expense for the six months ended June 30, 2026 and 2025 were as follows: Three Months Ended June 30, Six Months Ended June 30, (in Millions) Lease Cost Classification 2026 2025 2026 2025 Lease Cost Operating lease cost Costs of sales and services / Selling, general and administrative expenses $ 9.7 $ 8.5 $ 17.9 $ 17.5 Variable lease cost Costs of sales and services / Selling, general and administrative expenses 1.7 2.9 3.5 6.3 Total lease cost $ 11.4 $ 11.4 $ 21.4 $ 23.8 June 30, 2026 Operating Lease Term and Discount Rate Weighted-average remaining lease term (years) 5.3 Weighted-average discount rate 5.1 % Three Months Ended June 30, Six Months Ended June 30, (in Millions) 2026 2025 2026 2025 Other Information Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ (10.2) $ (9.6) $ (19.0) $ (19.7) Suppleme …
LesseeOperatingLeasesTextBlock · excerpt; the full note is in the filing
New accounting pronouncements · 679 characters as filed
New accounting guidance and regulatory items On November 4, 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income (Topic 220): Expense Disaggregation Disclosures, to require disaggregation of certain expense captions into specified categories in disclosures within the notes of the financial statements. The standard is effective for FMC beginning with the Form 10-K for the year ended December 31, 2027, and early adoption is permitted. The guidance is required to be applied prospectively and amendments in the ASU may be applied prospectively or retrospectively. We are currently evaluating the impact this standard will have on our disclosures.
NewAccountingPronouncementsPolicyPolicyTextBlock
Pensions and post-retirement benefits · 900 characters as filed
Pensions and Other Postretirement Benefits The following table summarizes the components of net annual benefit cost (income): (in Millions) Three Months Ended June 30, Six Months Ended June 30, Pensions Other Benefits Pensions Other Benefits 2026 2025 2026 2025 2026 2025 2026 2025 Service cost $ 0.3 $ 0.3 $ $ $ 0.6 $ 0.7 $ $ Interest cost 10.7 11.9 0.1 21.4 23.9 0.1 0.2 Expected return on plan assets (11.3) (11.9) (22.6) (24.1) Amortization of net actuarial and other (gain) loss 3.5 3.4 (0.1) (0.2) 7.0 6.9 (0.5) (0.5) Recognized (gain) loss due to curtailments, settlements, and other (1) 0.4 0.1 1.2 0.2 Net periodic benefit cost (income) $ 3.6 $ 3.8 $ (0.1) $ (0.1) $ 7.6 $ 7.6 $ (0.4) $ (0.3) ____________________ (1) The settlement charge recognized during the three and six months ended June 30, 2026 relates to the U.S. nonqualified defined benefit pension plan. …
PensionAndOtherPostretirementBenefitsDisclosureTextBlock · excerpt; the full note is in the filing
Revenue recognition · 5,691 characters as filed
Revenue Recognition Disaggregation of revenue We disaggregate revenue from contracts with customers by geographical areas and major product categories. We have three major agricultural product categories: insecticides, herbicides, and fungicides. Plant health, which includes biological products, is also included in the below table. The following table provides information about disaggregated revenue by major geographical region: Three Months Ended June 30, Six Months Ended June 30, (in Millions) 2026 2025 2026 2025 North America $ 248.8 $ 320.9 $ 446.4 $ 507.3 Latin America 277.9 310.4 454.9 517.2 Europe, Middle East & Africa (EMEA) 214.1 260.4 521.0 533.2 Asia 126.3 158.8 203.4 284.2 Total Revenue $ 867.1 $ 1,050.5 $ 1,625.7 $ 1,841.9 The following table provides information about disaggregated revenue by major product category: Three Months Ended June 30, Six Months Ended June 30, (in Millions) 2026 2025 2026 2025 Insecticides $ 423.5 $ 525.3 $ 764.1 $ 928.0 Herbicides 318.2 376.0 631.9 648.2 Fungicides 88.4 80.4 144.2 133.1 Plant Health 36.3 44.9 84.1 90.1 Other 0.7 23.9 1.4 42.5 Total Revenue $ 867.1 $ 1,050.5 $ 1,625.7 $ 1,841.9 We earn revenue from the sale of a wide range of products to a diversified base of customers around the world. We develop, market and sell all three major classes of crop protection chemicals (insecticides, herbicides and fungicides) as well as biologicals, crop nutrition, and seed treatment products, which we group as plant health. These pro …
RevenueFromContractWithCustomerTextBlock · excerpt; the full note is in the filing
Stockholders' equity · 6,096 characters as filed
Equity Accumulated other comprehensive income (loss) Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax. (in Millions) Foreign currency adjustments Derivative Instruments (1) Pension and other postretirement benefits Total Accumulated other comprehensive income (loss), net of tax at December 31, 2025 $ (135.1) $ (29.7) $ (203.9) $ (368.7) 2026 Activity Other comprehensive income (loss) before reclassifications 33.3 11.9 (0.2) 45.0 Amounts reclassified from accumulated other comprehensive income (loss) (6.9) 5.9 (1.0) Net current period other comprehensive income (loss) $ 33.3 $ 5.0 $ 5.7 $ 44.0 Accumulated other comprehensive income (loss), net of tax at June 30, 2026 $ (101.8) $ (24.7) $ (198.2) $ (324.7) (in Millions) Foreign currency adjustments Derivative Instruments (1) Pension and other postretirement benefits Total Accumulated other comprehensive income (loss), net of tax at December 31, 2024 $ (183.9) $ (17.5) $ (209.2) $ (410.6) 2025 Activity Other comprehensive income (loss) before reclassifications 39.6 (36.7) 2.9 Amounts reclassified from accumulated other comprehensive income (loss) (1.2) 5.2 4.0 Net current period other comprehensive income (loss) $ 39.6 $ (37.9) $ 5.2 $ 6.9 Accumulated other comprehensive income (loss), net of tax at June 30, 2025 $ (144.3) $ (55.4) $ (204.0) $ (403.7) ____________________ (1) See Note 17 for more information. Reclassifications of accumulated other comprehensive income (loss) The t …
StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing
Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.